Ocko Matthew

CIK 00018360895 companiesLONG BEACH, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001836089

Recent Transactions

50 trades

Sale
Rocket Lab Corp$RKLB
Common Stock
2025-09-16$48.53/sh−138,901→ 641,076 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-09-16$52.23/sh−24,955→ 1,331,569 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-09-16$47.49/sh−303,076→ 779,977 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-09-16$49.24/sh−165,753→ 1,410,602 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-09-16$51.79/sh−9,000→ 551,674 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-09-16$51.79/sh−22,130→ 1,356,524 total
Other
Rocket Lab Corp$RKLB
Common Stock
2025-09-16−1,331,569→ 0 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-09-16$47.49/sh−745,239→ 1,917,900 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-09-16$48.53/sh−341,545→ 1,576,355 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-09-16$50.24/sh−31,948→ 1,378,654 total
Other
Rocket Lab Corp$RKLB
Common Stock
2025-09-16−9,894→ 9,894 total
Other
Rocket Lab Corp$RKLB
Common Stock
2025-09-16−164,026→ 164,026 total
Other
Rocket Lab Corp$RKLB
Common Stock
2025-09-16−541,526→ 0 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-09-16$52.23/sh−10,148→ 541,526 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-09-16$50.24/sh−12,993→ 560,674 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-09-16$49.24/sh−67,409→ 573,667 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-06-13$26.01/sh−582,932→ 2,663,139 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-06-13$26.01/sh−237,068→ 1,083,053 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-06-12$26.44/sh−142,178→ 3,246,071 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2025-06-12$26.44/sh−57,822→ 1,320,121 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2024-11-15$18.21/sh−2,393,001→ 3,388,249 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2024-11-15$18.21/sh−973,192→ 1,377,943 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2024-11-14$17.73/sh−1,421,785→ 5,781,250 total
Sale
Rocket Lab Corp$RKLB
Common Stock
2024-11-14$17.73/sh−578,215→ 2,351,135 total
Disposition to Issuer
Zymergen Inc.
Common Stock
2022-10-19−2,448,901→ 0 total
Disposition to Issuer
Zymergen Inc.
Common Stock
2022-10-19−4,917,734→ 0 total
Purchase
Embark Technology, Inc.
Class A Common Stock
2022-08-30$9.64/sh+10,000→ 3,212,107 total
Purchase
Embark Technology, Inc.
Class A Common Stock
2022-08-18$11.64/sh+10,000→ 3,202,107 total
Purchase
Embark Technology, Inc.
Class A Common Stock
2022-08-16$0.84/sh+122,000→ 3,192,107 total
Other
AbCellera Biologics Inc.$ABCL
Common Shares
2021-06-18−5,000,000→ 24,105,761 total
Other
AbCellera Biologics Inc.$ABCL
Common Shares
2021-06-18+73,892→ 73,892 total
Conversion
Zymergen Inc.
Common Stock
2021-04-26+2,936,283→ 2,936,283 total
Conversion
Zymergen Inc.
Common Stock
2021-04-26+2,014,506→ 2,224,956 total
Conversion
Zymergen Inc.
Common Stock
2021-04-26+1,687,050→ 4,623,333 total
Conversion
Zymergen Inc.
Series C Preferred Stock
2021-04-26−294,401→ 0 total
Conversion
Zymergen Inc.
Series B Preferred Stock
2021-04-26−1,684,397→ 0 total
Conversion
Zymergen Inc.
Series A Preferred Stock
2021-04-26−2,936,283→ 0 total
Conversion
Zymergen Inc.
Common Stock
2021-04-26+223,945→ 2,448,901 total
Conversion
Zymergen Inc.
Series D Preferred Stock
2021-04-26−223,945→ 0 total
Conversion
Zymergen Inc.
Series A Preferred Stock
2021-04-26−210,450→ 0 total
Conversion
Zymergen Inc.
Common Stock
2021-04-26+294,401→ 4,917,734 total
Conversion
Zymergen Inc.
Series A-1 Preferred Stock
2021-04-26−2,014,506→ 0 total
Conversion
Zymergen Inc.
Common Stock
2021-04-26+210,450→ 210,450 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20+5,941,120→ 5,941,120 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20+3,951,141→ 3,951,141 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20−5,941,120→ 0 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20−3,951,141→ 0 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20−3,726,963→ 0 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2021-04-20+3,726,963→ 3,726,963 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series B Preferred Stock
2021-04-20−1,073,595→ 0 total

Companies

Recent Filings

Address

C/O ROCKET LAB CORPORATION 3881 MCGOWEN STREET

LONG BEACH, CA, 90808

View on SEC.gov